IQVIA
IQV
$216.20
Share price
-1.97%
Change (1 day)
-16.61%
Change (1 year)
Earnings for IQVIA (IQV)
Earnings in 2022 (TTM): $1.84 B
According to IQVIA's latest financial reports the company's current earnings (TTM) are $1.84 B. In 2021 the company made an earning of $1.50 B an increase over its 2020 earnings that were of $0.78 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for IQVIA from 2012 to 2022
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2022 (TTM) | $1.84 B | 22.55% |
| 2021 | $1.50 B | 90.49% |
| 2020 | $0.78 B | -1.25% |
| 2019 | $0.79 B | 7.68% |
| 2018 | $0.74 B | 9.6% |
| 2017 | $0.67 B | 8.67% |
| 2016 | $0.62 B | -2.78% |
| 2015 | $0.64 B | 6.31% |
| 2014 | $0.60 B | 34.96% |
| 2013 | $0.44 B | 11.16% |
| 2012 | $0.40 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$12.92 M | -100.70% | Bahamas |
 NRC Health
NRC | $47.15 M | -97.44% | 🇺🇸 USA |